News | Radiology Business | April 24, 2019

ITN Wins Jesse H. Neal Award for Best Technical Content

Team coverage of gadolinium controversy earns ITN first “Pulitzer Prize of the business press”

ITN Wins Jesse H. Neal Award for Best Technical Content

April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. Neal Award winner in the Best Technical Content category for its team coverage of the topic of gadolinium.

The Jesse H. Neal Awards, sponsored and hosted by Connectiv, a division of the Software & Information Industry Association, are recognized as the “Pulitzer Prize of the business press.” The winners are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship. 2019 marked the first Neal Awards win in ITN’s history.

Gadolinium has become a hot-button patient safety issue in radiology due to a possible link to neurological disorders in some patients who undergo a magnetic resonance imaging (MRI) scan using a gadolinium contrast agent. A 2015 study showed small levels of gadolinium, a heavy metal, remained deposited in the brain following repeated intravenous exposures to gadolinium-based contrast agents (GBCAs). The issue was also fueled by numerous patient groups claiming they suffer from numerous unexplained health issues after gadolinium exams, and movie star Chuck Norris filed a high-profile lawsuit alleging gadolinium permanently harmed his wife.

ITN editors joined several gadolinium patient groups on Facebook and read through hundreds of posts to gather the patient perspective. These groups were asked what questions they wanted posed to key MRI thought leaders, resulting in hundreds of comments. The responses formed the basis for interviews at the 2017 Radiological Society of North America (RSNA) meeting. ITN also shot video interviews with thought leaders and attended several sessions on this topic. The article was published online in February 2018. While written for radiologists, it was also geared it to be a resource for patients. It outlines the chemistry of gadolinium agents, symptoms patients report and regulatory actions taken. Extra search engine optimization (SEO) helped it on Google to appear on Page 1 of all searches for the topic. The result was was the best performing article ever on ITN, with more than 93,000 pageviewsin 2018. This one article now outperforms ITN's homepage traffic.

Click here to see all the 2019 Jesse H. Neal Awards winners.

For more information: www.itnonline.com

Related Content of MRI Gadolinium Safety Concerns

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI

Related Content

New MRI Technique Captures Brain Changes in Near-real Time

Differences in stiffness between stimulus states. Image courtesy of Patz et al.

News | Neuro Imaging | August 19, 2019
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an...
ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...